The name of this superfamily has been modified since the most recent official CATH+ release (v4_4_0). At the point of the last release, this superfamily was named:
"Phosphorylase Kinase; domain 1
".
FunFam 24: B-Raf proto-oncogene serine/threonine-protein kina...
Please note: GO annotations are assigned to the full protein sequence rather than individual protein domains. Since a given protein can contain multiple domains, it is possible that some of the annotations below come from additional domains that occur in the same protein, but have been classified elsewhere in CATH.
There are 33 GO terms relating to "molecular function"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
Protein binding GO:0005515
Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
|
28 |
F1M9C3 (/IPI)
P04049 (/IPI)
P04049 (/IPI)
P04049 (/IPI)
P04049 (/IPI)
P04049 (/IPI)
P04049 (/IPI)
P04049 (/IPI)
P04049 (/IPI)
P04049 (/IPI)
(18 more) |
Protein serine/threonine kinase activity GO:0004674
Catalysis of the reactions: ATP + protein serine = ADP + protein serine phosphate, and ATP + protein threonine = ADP + protein threonine phosphate.
|
21 |
F1M9C3 (/IDA)
P04049 (/IDA)
P04049 (/IDA)
P04049 (/IDA)
P04049 (/IDA)
P04049 (/IDA)
P04049 (/IDA)
P04049 (/IDA)
P04049 (/IDA)
P04049 (/IDA)
(11 more) |
Protein kinase activity GO:0004672
Catalysis of the phosphorylation of an amino acid residue in a protein, usually according to the reaction: a protein + ATP = a phosphoprotein + ADP.
|
18 |
P04049 (/TAS)
P04049 (/TAS)
P04049 (/TAS)
P04049 (/TAS)
P04049 (/TAS)
P04049 (/TAS)
P04049 (/TAS)
P04049 (/TAS)
P04049 (/TAS)
P10398 (/TAS)
(8 more) |
Identical protein binding GO:0042802
Interacting selectively and non-covalently with an identical protein or proteins.
|
12 |
P04049 (/IPI)
P04049 (/IPI)
P04049 (/IPI)
P04049 (/IPI)
P04049 (/IPI)
P04049 (/IPI)
P04049 (/IPI)
P04049 (/IPI)
P04049 (/IPI)
P15056 (/IPI)
(2 more) |
Enzyme binding GO:0019899
Interacting selectively and non-covalently with any enzyme.
|
9 | P04049 (/IPI) P04049 (/IPI) P04049 (/IPI) P04049 (/IPI) P04049 (/IPI) P04049 (/IPI) P04049 (/IPI) P04049 (/IPI) P04049 (/IPI) |
MAP kinase kinase kinase activity GO:0004709
Catalysis of the phosphorylation and activation of a MAP kinase kinase; each MAP kinase kinase can be phosphorylated by any of several MAP kinase kinase kinases.
|
6 | F1M9C3 (/IDA) P11345 (/IDA) P11346 (/IDA) P11346 (/IDA) P11346 (/IDA) P14056 (/IDA) |
SMAD binding GO:0046332
Interacting selectively and non-covalently with a SMAD signaling protein.
|
6 | A0A0A1GRF4 (/IDA) A0A0A1GU50 (/IDA) Q5FBD1 (/IDA) Q5M7Y2 (/IDA) Q75W79 (/IDA) Q75Y03 (/IDA) |
Protein kinase activity GO:0004672
Catalysis of the phosphorylation of an amino acid residue in a protein, usually according to the reaction: a protein + ATP = a phosphoprotein + ADP.
|
4 | P15056 (/IDA) P15056 (/IDA) P15056 (/IDA) P28028 (/IDA) |
Protein serine/threonine kinase activity GO:0004674
Catalysis of the reactions: ATP + protein serine = ADP + protein serine phosphate, and ATP + protein threonine = ADP + protein threonine phosphate.
|
3 | P04627 (/ISO) P28028 (/ISO) Q99N57 (/ISO) |
MAP kinase kinase kinase activity GO:0004709
Catalysis of the phosphorylation and activation of a MAP kinase kinase; each MAP kinase kinase can be phosphorylated by any of several MAP kinase kinase kinases.
|
3 | P04627 (/ISO) P28028 (/ISO) Q99N57 (/ISO) |
Calcium ion binding GO:0005509
Interacting selectively and non-covalently with calcium ions (Ca2+).
|
3 | P15056 (/IDA) P15056 (/IDA) P15056 (/IDA) |
MAP kinase kinase kinase activity GO:0004709
Catalysis of the phosphorylation and activation of a MAP kinase kinase; each MAP kinase kinase can be phosphorylated by any of several MAP kinase kinase kinases.
|
2 | F1M9C3 (/IMP) P11345 (/IMP) |
MAP kinase kinase kinase activity GO:0004709
Catalysis of the phosphorylation and activation of a MAP kinase kinase; each MAP kinase kinase can be phosphorylated by any of several MAP kinase kinase kinases.
|
2 | P11345 (/TAS) P14056 (/TAS) |
Protein tyrosine kinase activity GO:0004713
Catalysis of the reaction: ATP + a protein tyrosine = ADP + protein tyrosine phosphate.
|
2 | P18160 (/IDA) Q75JK0 (/IDA) |
Mitogen-activated protein kinase kinase binding GO:0031434
Interacting selectively and non-covalently with a mitogen-activated protein kinase kinase, any protein that can phosphorylate a MAP kinase.
|
2 | F1M9C3 (/IMP) P11345 (/IMP) |
Mitogen-activated protein kinase kinase binding GO:0031434
Interacting selectively and non-covalently with a mitogen-activated protein kinase kinase, any protein that can phosphorylate a MAP kinase.
|
2 | P28028 (/ISO) Q99N57 (/ISO) |
Identical protein binding GO:0042802
Interacting selectively and non-covalently with an identical protein or proteins.
|
2 | P28028 (/ISO) Q99N57 (/ISO) |
Protein heterodimerization activity GO:0046982
Interacting selectively and non-covalently with a nonidentical protein to form a heterodimer.
|
2 | F1M9C3 (/IPI) P11345 (/IPI) |
Protein heterodimerization activity GO:0046982
Interacting selectively and non-covalently with a nonidentical protein to form a heterodimer.
|
2 | P28028 (/ISO) Q99N57 (/ISO) |
Protein kinase activity GO:0004672
Catalysis of the phosphorylation of an amino acid residue in a protein, usually according to the reaction: a protein + ATP = a phosphoprotein + ADP.
|
1 | P28028 (/ISO) |
CAMP-dependent protein kinase activity GO:0004691
Catalysis of the reaction: ATP + a protein = ADP + a phosphoprotein. This reaction requires the presence of cAMP.
|
1 | Q75JK0 (/IMP) |
Protein serine/threonine/tyrosine kinase activity GO:0004712
Catalysis of the reactions: ATP + a protein serine = ADP + protein serine phosphate; ATP + a protein threonine = ADP + protein threonine phosphate; and ATP + a protein tyrosine = ADP + protein tyrosine phosphate.
|
1 | P18160 (/IDA) |
Calcium ion binding GO:0005509
Interacting selectively and non-covalently with calcium ions (Ca2+).
|
1 | P28028 (/ISO) |
ATP binding GO:0005524
Interacting selectively and non-covalently with ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator.
|
1 | P11345 (/IDA) |
ATP binding GO:0005524
Interacting selectively and non-covalently with ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator.
|
1 | Q99N57 (/ISO) |
Adenylate cyclase binding GO:0008179
Interacting selectively and non-covalently with the enzyme adenylate cyclase.
|
1 | P11345 (/IPI) |
Adenylate cyclase binding GO:0008179
Interacting selectively and non-covalently with the enzyme adenylate cyclase.
|
1 | Q99N57 (/ISO) |
Adenylate cyclase activator activity GO:0010856
Increases the activity of the enzyme that catalyzes the reaction: ATP = 3',5'-cyclic AMP + diphosphate.
|
1 | P11345 (/IDA) |
Adenylate cyclase activator activity GO:0010856
Increases the activity of the enzyme that catalyzes the reaction: ATP = 3',5'-cyclic AMP + diphosphate.
|
1 | Q99N57 (/ISO) |
Ras GTPase binding GO:0017016
Interacting selectively and non-covalently with any member of the Ras superfamily of monomeric GTPases.
|
1 | F1M9C3 (/IDA) |
Ras GTPase binding GO:0017016
Interacting selectively and non-covalently with any member of the Ras superfamily of monomeric GTPases.
|
1 | Q99N57 (/IPI) |
Ras GTPase binding GO:0017016
Interacting selectively and non-covalently with any member of the Ras superfamily of monomeric GTPases.
|
1 | P28028 (/ISO) |
Enzyme binding GO:0019899
Interacting selectively and non-covalently with any enzyme.
|
1 | Q99N57 (/ISO) |
There are 163 GO terms relating to "biological process"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
MAPK cascade GO:0000165
An intracellular protein kinase cascade containing at least a MAPK, a MAPKK and a MAP3K. The cascade can also contain an additional tiers: the upstream MAP4K. The kinases in each tier phosphorylate and activate the kinase in the downstream tier to transmit a signal within a cell.
|
17 |
P04049 (/TAS)
P04049 (/TAS)
P04049 (/TAS)
P04049 (/TAS)
P04049 (/TAS)
P04049 (/TAS)
P04049 (/TAS)
P04049 (/TAS)
P04049 (/TAS)
P10398 (/TAS)
(7 more) |
Positive regulation of peptidyl-serine phosphorylation GO:0033138
Any process that activates or increases the frequency, rate or extent of the phosphorylation of peptidyl-serine.
|
17 |
P04049 (/IDA)
P04049 (/IDA)
P04049 (/IDA)
P04049 (/IDA)
P04049 (/IDA)
P04049 (/IDA)
P04049 (/IDA)
P04049 (/IDA)
P04049 (/IDA)
P10398 (/IDA)
(7 more) |
Negative regulation of apoptotic process GO:0043066
Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process.
|
17 |
P04049 (/IDA)
P04049 (/IDA)
P04049 (/IDA)
P04049 (/IDA)
P04049 (/IDA)
P04049 (/IDA)
P04049 (/IDA)
P04049 (/IDA)
P04049 (/IDA)
P10398 (/IDA)
(7 more) |
Protein phosphorylation GO:0006468
The process of introducing a phosphate group on to a protein.
|
14 |
P04049 (/TAS)
P04049 (/TAS)
P04049 (/TAS)
P04049 (/TAS)
P04049 (/TAS)
P04049 (/TAS)
P04049 (/TAS)
P04049 (/TAS)
P04049 (/TAS)
P11345 (/TAS)
(4 more) |
Activation of MAPKK activity GO:0000186
The initiation of the activity of the inactive enzyme MAP kinase kinase (MAPKK).
|
9 | P04049 (/IDA) P04049 (/IDA) P04049 (/IDA) P04049 (/IDA) P04049 (/IDA) P04049 (/IDA) P04049 (/IDA) P04049 (/IDA) P04049 (/IDA) |
Stimulatory C-type lectin receptor signaling pathway GO:0002223
Any series of molecular signals generated as a consequence of binding to a C-type lectin receptor capable of cellular activation.
|
9 | P04049 (/TAS) P04049 (/TAS) P04049 (/TAS) P04049 (/TAS) P04049 (/TAS) P04049 (/TAS) P04049 (/TAS) P04049 (/TAS) P04049 (/TAS) |
Apoptotic process GO:0006915
A programmed cell death process which begins when a cell receives an internal (e.g. DNA damage) or external signal (e.g. an extracellular death ligand), and proceeds through a series of biochemical events (signaling pathway phase) which trigger an execution phase. The execution phase is the last step of an apoptotic process, and is typically characterized by rounding-up of the cell, retraction of pseudopodes, reduction of cellular volume (pyknosis), chromatin condensation, nuclear fragmentation (karyorrhexis), plasma membrane blebbing and fragmentation of the cell into apoptotic bodies. When the execution phase is completed, the cell has died.
|
9 | P04049 (/TAS) P04049 (/TAS) P04049 (/TAS) P04049 (/TAS) P04049 (/TAS) P04049 (/TAS) P04049 (/TAS) P04049 (/TAS) P04049 (/TAS) |
Signal transduction GO:0007165
The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell.
|
9 | P04049 (/TAS) P04049 (/TAS) P04049 (/TAS) P04049 (/TAS) P04049 (/TAS) P04049 (/TAS) P04049 (/TAS) P04049 (/TAS) P04049 (/TAS) |
Activation of adenylate cyclase activity GO:0007190
Any process that initiates the activity of the inactive enzyme adenylate cyclase.
|
9 | P04049 (/IDA) P04049 (/IDA) P04049 (/IDA) P04049 (/IDA) P04049 (/IDA) P04049 (/IDA) P04049 (/IDA) P04049 (/IDA) P04049 (/IDA) |
Negative regulation of cell population proliferation GO:0008285
Any process that stops, prevents or reduces the rate or extent of cell proliferation.
|
9 | P04049 (/IDA) P04049 (/IDA) P04049 (/IDA) P04049 (/IDA) P04049 (/IDA) P04049 (/IDA) P04049 (/IDA) P04049 (/IDA) P04049 (/IDA) |
Platelet activation GO:0030168
A series of progressive, overlapping events triggered by exposure of the platelets to subendothelial tissue. These events include shape change, adhesiveness, aggregation, and release reactions. When carried through to completion, these events lead to the formation of a stable hemostatic plug.
|
9 | P04049 (/TAS) P04049 (/TAS) P04049 (/TAS) P04049 (/TAS) P04049 (/TAS) P04049 (/TAS) P04049 (/TAS) P04049 (/TAS) P04049 (/TAS) |
Negative regulation of protein complex assembly GO:0031333
Any process that stops, prevents, or reduces the frequency, rate or extent of protein complex assembly.
|
9 | P04049 (/IDA) P04049 (/IDA) P04049 (/IDA) P04049 (/IDA) P04049 (/IDA) P04049 (/IDA) P04049 (/IDA) P04049 (/IDA) P04049 (/IDA) |
Ion transmembrane transport GO:0034220
A process in which an ion is transported across a membrane.
|
9 | P04049 (/TAS) P04049 (/TAS) P04049 (/TAS) P04049 (/TAS) P04049 (/TAS) P04049 (/TAS) P04049 (/TAS) P04049 (/TAS) P04049 (/TAS) |
Regulation of Rho protein signal transduction GO:0035023
Any process that modulates the frequency, rate or extent of Rho protein signal transduction.
|
9 | P04049 (/TAS) P04049 (/TAS) P04049 (/TAS) P04049 (/TAS) P04049 (/TAS) P04049 (/TAS) P04049 (/TAS) P04049 (/TAS) P04049 (/TAS) |
Wound healing GO:0042060
The series of events that restore integrity to a damaged tissue, following an injury.
|
9 | P04049 (/TAS) P04049 (/TAS) P04049 (/TAS) P04049 (/TAS) P04049 (/TAS) P04049 (/TAS) P04049 (/TAS) P04049 (/TAS) P04049 (/TAS) |
Regulation of apoptotic process GO:0042981
Any process that modulates the occurrence or rate of cell death by apoptotic process.
|
9 | P04049 (/TAS) P04049 (/TAS) P04049 (/TAS) P04049 (/TAS) P04049 (/TAS) P04049 (/TAS) P04049 (/TAS) P04049 (/TAS) P04049 (/TAS) |
Negative regulation of cysteine-type endopeptidase activity involved in apoptotic process GO:0043154
Any process that stops, prevents, or reduces the frequency, rate or extent of a cysteine-type endopeptidase activity involved in the apoptotic process.
|
9 | P04049 (/TAS) P04049 (/TAS) P04049 (/TAS) P04049 (/TAS) P04049 (/TAS) P04049 (/TAS) P04049 (/TAS) P04049 (/TAS) P04049 (/TAS) |
Regulation of cell differentiation GO:0045595
Any process that modulates the frequency, rate or extent of cell differentiation, the process in which relatively unspecialized cells acquire specialized structural and functional features.
|
9 | P04049 (/TAS) P04049 (/TAS) P04049 (/TAS) P04049 (/TAS) P04049 (/TAS) P04049 (/TAS) P04049 (/TAS) P04049 (/TAS) P04049 (/TAS) |
Regulation of cell motility GO:2000145
Any process that modulates the frequency, rate or extent of cell motility.
|
9 | P04049 (/TAS) P04049 (/TAS) P04049 (/TAS) P04049 (/TAS) P04049 (/TAS) P04049 (/TAS) P04049 (/TAS) P04049 (/TAS) P04049 (/TAS) |
Protein phosphorylation GO:0006468
The process of introducing a phosphate group on to a protein.
|
8 | F1M9C3 (/IDA) P11345 (/IDA) P14056 (/IDA) P15056 (/IDA) P15056 (/IDA) P15056 (/IDA) P28028 (/IDA) Q75JK0 (/IDA) |
Activation of MAPKK activity GO:0000186
The initiation of the activity of the inactive enzyme MAP kinase kinase (MAPKK).
|
6 | A0A0R4IC22 (/IGI) A0A0R4IN14 (/IGI) D3KYU7 (/IGI) Q6BE22 (/IGI) Q76FQ3 (/IGI) Q7ZTR8 (/IGI) |
Heart development GO:0007507
The process whose specific outcome is the progression of the heart over time, from its formation to the mature structure. The heart is a hollow, muscular organ, which, by contracting rhythmically, keeps up the circulation of the blood.
|
6 | A0A0R4IC22 (/IMP) A0A0R4IN14 (/IMP) D3KYU7 (/IMP) Q6BE22 (/IMP) Q76FQ3 (/IMP) Q7ZTR8 (/IMP) |
Pathway-restricted SMAD protein phosphorylation GO:0060389
The process of introducing a phosphate group on to a pathway restricted SMAD protein. A pathway restricted SMAD protein is an effector protein that acts directly downstream of the transforming growth factor family receptor.
|
6 | A0A0A1GRF4 (/IDA) A0A0A1GU50 (/IDA) Q5FBD1 (/IDA) Q5M7Y2 (/IDA) Q75W79 (/IDA) Q75Y03 (/IDA) |
Negative regulation of nodal signaling pathway GO:1900108
Any process that stops, prevents or reduces the frequency, rate or extent of nodal signaling pathway.
|
6 | A0A0A1GRF4 (/IDA) A0A0A1GU50 (/IDA) Q5FBD1 (/IDA) Q5M7Y2 (/IDA) Q75W79 (/IDA) Q75Y03 (/IDA) |
Negative regulation of nodal signaling pathway GO:1900108
Any process that stops, prevents or reduces the frequency, rate or extent of nodal signaling pathway.
|
6 | A0A0A1GRF4 (/IMP) A0A0A1GU50 (/IMP) Q5FBD1 (/IMP) Q5M7Y2 (/IMP) Q75W79 (/IMP) Q75Y03 (/IMP) |
Cellular protein modification process GO:0006464
The covalent alteration of one or more amino acids occurring in proteins, peptides and nascent polypeptides (co-translational, post-translational modifications) occurring at the level of an individual cell. Includes the modification of charged tRNAs that are destined to occur in a protein (pre-translation modification).
|
5 | P10398 (/TAS) P10398 (/TAS) P10398 (/TAS) P10398 (/TAS) P10398 (/TAS) |
Regulation of TOR signaling GO:0032006
Any process that modulates the frequency, rate or extent of TOR signaling.
|
5 | P10398 (/IMP) P10398 (/IMP) P10398 (/IMP) P10398 (/IMP) P10398 (/IMP) |
Regulation of proteasomal ubiquitin-dependent protein catabolic process GO:0032434
Any process that modulates the frequency, rate or extent of the breakdown of a protein or peptide by hydrolysis of its peptide bonds, initiated by the covalent attachment of ubiquitin, and mediated by the proteasome.
|
5 | P10398 (/IMP) P10398 (/IMP) P10398 (/IMP) P10398 (/IMP) P10398 (/IMP) |
Protein autophosphorylation GO:0046777
The phosphorylation by a protein of one or more of its own amino acid residues (cis-autophosphorylation), or residues on an identical protein (trans-autophosphorylation).
|
4 | P11346 (/IDA) P11346 (/IDA) P11346 (/IDA) Q75JK0 (/IDA) |
Positive regulation of ERK1 and ERK2 cascade GO:0070374
Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the ERK1 and ERK2 cascade.
|
4 | P15056 (/IDA) P15056 (/IDA) P15056 (/IDA) P28028 (/IDA) |
Instar larval development GO:0002168
The process whose specific outcome is the progression of the larva over time, from its formation to the mature structure. This begins with the newly hatched first-instar larva, through its maturation to the end of the last larval stage. An example of this process is found in Drosophila melanogaster.
|
3 | P11346 (/IMP) P11346 (/IMP) P11346 (/IMP) |
Protein phosphorylation GO:0006468
The process of introducing a phosphate group on to a protein.
|
3 | P04627 (/ISO) P28028 (/ISO) Q99N57 (/ISO) |
Epidermal growth factor receptor signaling pathway GO:0007173
A series of molecular signals initiated by binding of a ligand to the tyrosine kinase receptor EGFR (ERBB1) on the surface of a cell. The pathway ends with regulation of a downstream cellular process, e.g. transcription.
|
3 | P11346 (/IGI) P11346 (/IGI) P11346 (/IGI) |
Epidermal growth factor receptor signaling pathway GO:0007173
A series of molecular signals initiated by binding of a ligand to the tyrosine kinase receptor EGFR (ERBB1) on the surface of a cell. The pathway ends with regulation of a downstream cellular process, e.g. transcription.
|
3 | P11346 (/IMP) P11346 (/IMP) P11346 (/IMP) |
Ras protein signal transduction GO:0007265
A series of molecular signals within the cell that are mediated by a member of the Ras superfamily of proteins switching to a GTP-bound active state.
|
3 | P11346 (/HGI) P11346 (/HGI) P11346 (/HGI) |
Spermatogenesis GO:0007283
The process of formation of spermatozoa, including spermatocytogenesis and spermiogenesis.
|
3 | P11346 (/IMP) P11346 (/IMP) P11346 (/IMP) |
Border follicle cell migration GO:0007298
The directed movement of a border cell through the nurse cells to reach the oocyte. An example of this is found in Drosophila melanogaster.
|
3 | P11346 (/IGI) P11346 (/IGI) P11346 (/IGI) |
Terminal region determination GO:0007362
Specification of the terminal regions (the two non-segmented ends) of the embryo by the gap genes; exemplified in insects by the actions of huckebein and tailless gene products.
|
3 | P11346 (/IMP) P11346 (/IMP) P11346 (/IMP) |
Gastrulation GO:0007369
A complex and coordinated series of cellular movements that occurs at the end of cleavage during embryonic development of most animals. The details of gastrulation vary from species to species, but usually result in the formation of the three primary germ layers, ectoderm, mesoderm and endoderm.
|
3 | P11346 (/IMP) P11346 (/IMP) P11346 (/IMP) |
Terminal branching, open tracheal system GO:0007430
Formation of terminal branches in the open tracheal system. These are long cytoplasmic extensions that form fine tubules that transport oxygen directly to the tissues. An example of the process is found in Drosophila melanogaster.
|
3 | P11346 (/IMP) P11346 (/IMP) P11346 (/IMP) |
R7 cell fate commitment GO:0007465
The process in which the R7 photoreceptor commits to its cell fate. The R7 receptor contributes the central part of the rhabdomere in the apical parts of the ommatidium.
|
3 | P11346 (/IGI) P11346 (/IGI) P11346 (/IGI) |
R7 cell fate commitment GO:0007465
The process in which the R7 photoreceptor commits to its cell fate. The R7 receptor contributes the central part of the rhabdomere in the apical parts of the ommatidium.
|
3 | P11346 (/IMP) P11346 (/IMP) P11346 (/IMP) |
Wing disc morphogenesis GO:0007472
The process in which the anatomical structures derived from the wing disc are generated and organized. This includes the transformation of a wing imaginal disc from a monolayered epithelium in the larvae of holometabolous insects into recognizable adult structures including the wing hinge, wing blade and pleura.
|
3 | P11346 (/IMP) P11346 (/IMP) P11346 (/IMP) |
Imaginal disc-derived wing vein specification GO:0007474
The regionalization process in which the area of a imaginal disc-derived wing that will form a wing vein is specified.
|
3 | P11346 (/IMP) P11346 (/IMP) P11346 (/IMP) |
Imaginal disc-derived wing morphogenesis GO:0007476
The process in which the anatomical structures of the imaginal disc-derived wing are generated and organized. The wing is an appendage modified for flying.
|
3 | P11346 (/IMP) P11346 (/IMP) P11346 (/IMP) |
Metamorphosis GO:0007552
A biological process in which an animal physically develops after birth or hatching, involving a conspicuous and relatively abrupt change in the animal's form or structure. Examples include the change from tadpole to frog, and the change from larva to adult. An example of this is found in Drosophila melanogaster.
|
3 | P11346 (/IMP) P11346 (/IMP) P11346 (/IMP) |
Circadian rhythm GO:0007623
Any biological process in an organism that recurs with a regularity of approximately 24 hours.
|
3 | P11346 (/TAS) P11346 (/TAS) P11346 (/TAS) |
Dorsal/ventral axis specification, ovarian follicular epithelium GO:0008069
Polarization of the ovarian follicle cells along the dorsal/ventral axis. An example of this process is found in Drosophila melanogaster.
|
3 | P11346 (/IMP) P11346 (/IMP) P11346 (/IMP) |
Positive regulation of cell population proliferation GO:0008284
Any process that activates or increases the rate or extent of cell proliferation.
|
3 | P11346 (/IMP) P11346 (/IMP) P11346 (/IMP) |
Torso signaling pathway GO:0008293
A series of molecular signals initiated by the binding of an extracellular ligand to torso (a receptor tyrosine kinase) on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription.
|
3 | P11346 (/IGI) P11346 (/IGI) P11346 (/IGI) |
Torso signaling pathway GO:0008293
A series of molecular signals initiated by the binding of an extracellular ligand to torso (a receptor tyrosine kinase) on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription.
|
3 | P11346 (/IMP) P11346 (/IMP) P11346 (/IMP) |
Fibroblast growth factor receptor signaling pathway GO:0008543
The series of molecular signals generated as a consequence of a fibroblast growth factor receptor binding to one of its physiological ligands.
|
3 | P11346 (/IGI) P11346 (/IGI) P11346 (/IGI) |
Fibroblast growth factor receptor signaling pathway GO:0008543
The series of molecular signals generated as a consequence of a fibroblast growth factor receptor binding to one of its physiological ligands.
|
3 | P11346 (/IMP) P11346 (/IMP) P11346 (/IMP) |
Cellular response to starvation GO:0009267
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of deprivation of nourishment.
|
3 | P11346 (/IMP) P11346 (/IMP) P11346 (/IMP) |
Animal organ morphogenesis GO:0009887
Morphogenesis of an animal organ. An organ is defined as a tissue or set of tissues that work together to perform a specific function or functions. Morphogenesis is the process in which anatomical structures are generated and organized. Organs are commonly observed as visibly distinct structures, but may also exist as loosely associated clusters of cells that work together to perform a specific function or functions.
|
3 | P15056 (/TAS) P15056 (/TAS) P15056 (/TAS) |
Positive regulation of gene expression GO:0010628
Any process that increases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
|
3 | P15056 (/IMP) P15056 (/IMP) P15056 (/IMP) |
Positive regulation of glucose transmembrane transport GO:0010828
Any process that increases the frequency, rate or extent of glucose transport across a membrane. Glucose transport is the directed movement of the hexose monosaccharide glucose into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
|
3 | P15056 (/IDA) P15056 (/IDA) P15056 (/IDA) |
Negative regulation of macroautophagy GO:0016242
Any process that stops, prevents, or reduces the frequency, rate or extent of macroautophagy.
|
3 | P11346 (/IMP) P11346 (/IMP) P11346 (/IMP) |
Regulation of cellular pH GO:0030641
Any process involved in the maintenance of an internal equilibrium of hydrogen ions (protons) within a cell or between a cell and its external environment.
|
3 | P11346 (/IGI) P11346 (/IGI) P11346 (/IGI) |
Regulation of TOR signaling GO:0032006
Any process that modulates the frequency, rate or extent of TOR signaling.
|
3 | O19004 (/ISS) P04627 (/ISS) P14056 (/ISS) |
Regulation of proteasomal ubiquitin-dependent protein catabolic process GO:0032434
Any process that modulates the frequency, rate or extent of the breakdown of a protein or peptide by hydrolysis of its peptide bonds, initiated by the covalent attachment of ubiquitin, and mediated by the proteasome.
|
3 | O19004 (/ISS) P04627 (/ISS) P14056 (/ISS) |
Positive regulation of peptidyl-serine phosphorylation GO:0033138
Any process that activates or increases the frequency, rate or extent of the phosphorylation of peptidyl-serine.
|
3 | P04627 (/ISO) P28028 (/ISO) Q99N57 (/ISO) |
Lamellocyte differentiation GO:0035171
The process in which a relatively unspecialized hemocyte precursor cell acquires the specialized features of a lamellocyte. Lamellocytes are a hemocyte lineage that exists only in larvae, but are seldom observed in healthy animals. Lamellocytes differentiate massively in the lymph glands after parasitization and are large flat cells devoted to encapsulation of invaders too large to be phagocytosed by plasmatocytes.
|
3 | P11346 (/IMP) P11346 (/IMP) P11346 (/IMP) |
Wing and notum subfield formation GO:0035309
The regionalization process that subdivides the wing imaginal disc into the wing and notum (body wall) subfields, thus determining whether cells ultimately differentiate wing or notum-specific structures.
|
3 | P11346 (/IGI) P11346 (/IGI) P11346 (/IGI) |
Intracellular signal transduction GO:0035556
The process in which a signal is passed on to downstream components within the cell, which become activated themselves to further propagate the signal and finally trigger a change in the function or state of the cell.
|
3 | P11345 (/TAS) P14056 (/TAS) Q99N57 (/TAS) |
Regulation of multicellular organism growth GO:0040014
Any process that modulates the frequency, rate or extent of growth of the body of an organism so that it reaches its usual body size.
|
3 | P11346 (/IMP) P11346 (/IMP) P11346 (/IMP) |
Compound eye photoreceptor development GO:0042051
The process whose specific outcome is the progression of a light-responsive receptor in the compound eye over time, from its formation to the mature structure.
|
3 | P11346 (/IMP) P11346 (/IMP) P11346 (/IMP) |
Hemocyte differentiation GO:0042386
The process in which a relatively unspecialized cell acquires the characteristics of a mature hemocyte. Hemocytes are blood cells associated with a hemocoel (the cavity containing most of the major organs of the arthropod body) which are involved in defense and clotting of hemolymph, but not involved in transport of oxygen.
|
3 | P11346 (/IGI) P11346 (/IGI) P11346 (/IGI) |
Hemocyte differentiation GO:0042386
The process in which a relatively unspecialized cell acquires the characteristics of a mature hemocyte. Hemocytes are blood cells associated with a hemocoel (the cavity containing most of the major organs of the arthropod body) which are involved in defense and clotting of hemolymph, but not involved in transport of oxygen.
|
3 | P11346 (/IMP) P11346 (/IMP) P11346 (/IMP) |
Photoreceptor cell development GO:0042461
Development of a photoreceptor, a cell that responds to incident electromagnetic radiation, particularly visible light.
|
3 | P11346 (/IGI) P11346 (/IGI) P11346 (/IGI) |
Negative regulation of apoptotic process GO:0043066
Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process.
|
3 | P04627 (/ISO) P28028 (/ISO) Q99N57 (/ISO) |
Negative regulation of apoptotic process GO:0043066
Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process.
|
3 | P15056 (/TAS) P15056 (/TAS) P15056 (/TAS) |
Sevenless signaling pathway GO:0045500
A series of molecular signals initiated by the binding of an extracellular ligand to sevenless (sev; a receptor tyrosine kinase) on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription.
|
3 | P11346 (/IGI) P11346 (/IGI) P11346 (/IGI) |
Sevenless signaling pathway GO:0045500
A series of molecular signals initiated by the binding of an extracellular ligand to sevenless (sev; a receptor tyrosine kinase) on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription.
|
3 | P11346 (/IMP) P11346 (/IMP) P11346 (/IMP) |
Photoreceptor cell differentiation GO:0046530
The specialization of organization of a photoreceptor, a cell that responds to incident electromagnetic radiation, particularly visible light. An example of this process is found in Drosophila melanogaster.
|
3 | P11346 (/IMP) P11346 (/IMP) P11346 (/IMP) |
Positive regulation of photoreceptor cell differentiation GO:0046534
Any process that activates or increases the frequency, rate or extent of photoreceptor cell differentiation. An example of this process is found in Drosophila melanogaster.
|
3 | P11346 (/IMP) P11346 (/IMP) P11346 (/IMP) |
Dorsal appendage formation GO:0046843
Establishment of the dorsal filaments, elaborate specializations of the chorion that protrude from the anterior end of the egg and facilitate embryonic respiration.
|
3 | P11346 (/IGI) P11346 (/IGI) P11346 (/IGI) |
Vascular endothelial growth factor receptor signaling pathway GO:0048010
Any series of molecular signals initiated by the binding of an extracellular ligand to a vascular endothelial growth factor receptor (VEGFR) located on the surface of the receiving cell, and ending with regulation of a downstream cellular process, e.g. transcription.
|
3 | P11346 (/IGI) P11346 (/IGI) P11346 (/IGI) |
ERK1 and ERK2 cascade GO:0070371
An intracellular protein kinase cascade containing at least ERK1 or ERK2 (MAPKs), a MEK (a MAPKK) and a MAP3K. The cascade may involve 4 different kinases, as it can also contain an additional tier: the upstream MAP4K. The kinases in each tier phosphorylate and activate the kinase in the downstream tier to transmit a signal within a cell.
|
3 | P11346 (/IDA) P11346 (/IDA) P11346 (/IDA) |
Positive regulation of ERK1 and ERK2 cascade GO:0070374
Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the ERK1 and ERK2 cascade.
|
3 | P11346 (/HGI) P11346 (/HGI) P11346 (/HGI) |
Trehalose metabolism in response to stress GO:0070413
The chemical reactions and pathways involving trehalose that occur as a result of a stimulus indicating the organism is under stress.
|
3 | P15056 (/IMP) P15056 (/IMP) P15056 (/IMP) |
Cellular response to calcium ion GO:0071277
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a calcium ion stimulus.
|
3 | P15056 (/IDA) P15056 (/IDA) P15056 (/IDA) |
Establishment of protein localization to membrane GO:0090150
The directed movement of a protein to a specific location in a membrane.
|
3 | P15056 (/IDA) P15056 (/IDA) P15056 (/IDA) |
Negative regulation of apoptotic signaling pathway GO:2001234
Any process that stops, prevents or reduces the frequency, rate or extent of apoptotic signaling pathway.
|
3 | P11346 (/IGI) P11346 (/IGI) P11346 (/IGI) |
Protein phosphorylation GO:0006468
The process of introducing a phosphate group on to a protein.
|
2 | F1M9C3 (/IMP) P11345 (/IMP) |
Cell differentiation GO:0030154
The process in which relatively unspecialized cells, e.g. embryonic or regenerative cells, acquire specialized structural and/or functional features that characterize the cells, tissues, or organs of the mature organism or some other relatively stable phase of the organism's life history. Differentiation includes the processes involved in commitment of a cell to a specific fate and its subsequent development to the mature state.
|
2 | P28028 (/IGI) Q99N57 (/IGI) |
Sporulation resulting in formation of a cellular spore GO:0030435
The process in which a relatively unspecialized cell acquires the specialized features of a cellular spore, a cell form that can be used for dissemination, for survival of adverse conditions because of its heat and dessication resistance, and/or for reproduction.
|
2 | P18160 (/IMP) Q75JK0 (/IMP) |
Thyroid gland development GO:0030878
The process whose specific outcome is the progression of the thyroid gland over time, from its formation to the mature structure. The thyroid gland is an endoderm-derived gland that produces thyroid hormone.
|
2 | P28028 (/IGI) Q99N57 (/IGI) |
Somatic stem cell population maintenance GO:0035019
Any process by which an organism retains a population of somatic stem cells, undifferentiated cells in the embryo or adult which can undergo unlimited division and give rise to cell types of the body other than those of the germ-line.
|
2 | P28028 (/IGI) Q99N57 (/IGI) |
Negative regulation of neuron apoptotic process GO:0043524
Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process in neurons.
|
2 | F1M9C3 (/IMP) P28028 (/IMP) |
Thymus development GO:0048538
The process whose specific outcome is the progression of the thymus over time, from its formation to the mature structure. The thymus is a symmetric bi-lobed organ involved primarily in the differentiation of immature to mature T cells, with unique vascular, nervous, epithelial, and lymphoid cell components.
|
2 | P28028 (/IGI) Q99N57 (/IGI) |
Face development GO:0060324
The biological process whose specific outcome is the progression of a face from an initial condition to its mature state. The face is the ventral division of the head.
|
2 | P28028 (/IGI) Q99N57 (/IGI) |
Positive regulation of ERK1 and ERK2 cascade GO:0070374
Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the ERK1 and ERK2 cascade.
|
2 | F1M9C3 (/IMP) P28028 (/IMP) |
MAPK cascade GO:0000165
An intracellular protein kinase cascade containing at least a MAPK, a MAPKK and a MAP3K. The cascade can also contain an additional tiers: the upstream MAP4K. The kinases in each tier phosphorylate and activate the kinase in the downstream tier to transmit a signal within a cell.
|
1 | P11345 (/IDA) |
MAPK cascade GO:0000165
An intracellular protein kinase cascade containing at least a MAPK, a MAPKK and a MAP3K. The cascade can also contain an additional tiers: the upstream MAP4K. The kinases in each tier phosphorylate and activate the kinase in the downstream tier to transmit a signal within a cell.
|
1 | P11345 (/IMP) |
MAPK cascade GO:0000165
An intracellular protein kinase cascade containing at least a MAPK, a MAPKK and a MAP3K. The cascade can also contain an additional tiers: the upstream MAP4K. The kinases in each tier phosphorylate and activate the kinase in the downstream tier to transmit a signal within a cell.
|
1 | Q99N57 (/ISO) |
Activation of MAPKK activity GO:0000186
The initiation of the activity of the inactive enzyme MAP kinase kinase (MAPKK).
|
1 | Q99N57 (/ISO) |
Response to hypoxia GO:0001666
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating lowered oxygen tension. Hypoxia, defined as a decline in O2 levels below normoxic levels of 20.8 - 20.95%, results in metabolic adaptation at both the cellular and organismal level.
|
1 | P11345 (/IDA) |
Response to hypoxia GO:0001666
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating lowered oxygen tension. Hypoxia, defined as a decline in O2 levels below normoxic levels of 20.8 - 20.95%, results in metabolic adaptation at both the cellular and organismal level.
|
1 | Q99N57 (/ISO) |
Cellular glucose homeostasis GO:0001678
A cellular homeostatic process involved in the maintenance of an internal steady state of glucose within a cell or between a cell and its external environment.
|
1 | Q99N57 (/IMP) |
Cell fate specification GO:0001708
The process involved in the specification of cell identity. Once specification has taken place, a cell will be committed to differentiate down a specific pathway if left in its normal environment.
|
1 | Q75JK0 (/IMP) |
Positive regulation of protein phosphorylation GO:0001934
Any process that activates or increases the frequency, rate or extent of addition of phosphate groups to amino acids within a protein.
|
1 | Q99N57 (/IMP) |
Myeloid progenitor cell differentiation GO:0002318
The process in which a precursor cell type acquires the specialized features of a myeloid progenitor cell. Myeloid progenitor cells include progenitor cells for any of the myeloid lineages.
|
1 | P28028 (/IMP) |
Signal transduction GO:0007165
The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell.
|
1 | Q75JK0 (/IDA) |
Activation of adenylate cyclase activity GO:0007190
Any process that initiates the activity of the inactive enzyme adenylate cyclase.
|
1 | Q99N57 (/ISO) |
Heart development GO:0007507
The process whose specific outcome is the progression of the heart over time, from its formation to the mature structure. The heart is a hollow, muscular organ, which, by contracting rhythmically, keeps up the circulation of the blood.
|
1 | P11345 (/IEP) |
Negative regulation of cell population proliferation GO:0008285
Any process that stops, prevents or reduces the rate or extent of cell proliferation.
|
1 | Q99N57 (/ISO) |
Visual learning GO:0008542
Any process in an organism in which a change in behavior of an individual occurs in response to repeated exposure to a visual cue.
|
1 | P28028 (/IMP) |
Anatomical structure morphogenesis GO:0009653
The process in which anatomical structures are generated and organized. Morphogenesis pertains to the creation of form.
|
1 | P18160 (/IMP) |
Positive regulation of gene expression GO:0010628
Any process that increases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
|
1 | P28028 (/IGI) |
Positive regulation of gene expression GO:0010628
Any process that increases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
|
1 | P28028 (/ISO) |
Negative regulation of fibroblast migration GO:0010764
Any process that decreases the rate, frequency or extent of fibroblast cell migration. Fibroblast cell migration is accomplished by extension and retraction of a pseudopodium.
|
1 | P28028 (/IMP) |
Positive regulation of glucose transmembrane transport GO:0010828
Any process that increases the frequency, rate or extent of glucose transport across a membrane. Glucose transport is the directed movement of the hexose monosaccharide glucose into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
|
1 | P28028 (/ISO) |
CAMP-mediated signaling GO:0019933
Any intracellular signal transduction in which the signal is passed on within the cell via cyclic AMP (cAMP). Includes production of cAMP, and downstream effectors that further transmit the signal within the cell.
|
1 | Q75JK0 (/IMP) |
Immortalization of host cell GO:0020021
The modification of a host cell into an immortal cell line as a consequence of infection. The host is defined as the larger of the organisms involved in a symbiotic interaction.
|
1 | P04627 (/IDA) |
Sorocarp development GO:0030587
The process whose specific outcome is the progression of the sorocarp over time, from its formation to the mature structure. The process begins with the aggregation of individual cells and ends with the mature sorocarp. The sorocarp is a structure containing a spore-bearing sorus that sits on top of a stalk. An example of this process is found in Dictyostelium discoideum.
|
1 | P18160 (/HMP) |
Sorocarp morphogenesis GO:0031288
The process in which the sorocarp is generated and organized. An example of this process is found in Dictyostelium discoideum.
|
1 | Q75JK0 (/IMP) |
Negative regulation of protein complex assembly GO:0031333
Any process that stops, prevents, or reduces the frequency, rate or extent of protein complex assembly.
|
1 | Q99N57 (/ISO) |
Regulation of TOR signaling GO:0032006
Any process that modulates the frequency, rate or extent of TOR signaling.
|
1 | P04627 (/ISO) |
Regulation of proteasomal ubiquitin-dependent protein catabolic process GO:0032434
Any process that modulates the frequency, rate or extent of the breakdown of a protein or peptide by hydrolysis of its peptide bonds, initiated by the covalent attachment of ubiquitin, and mediated by the proteasome.
|
1 | P04627 (/ISO) |
Positive regulation of kinase activity GO:0033674
Any process that activates or increases the frequency, rate or extent of kinase activity, the catalysis of the transfer of a phosphate group, usually from ATP, to a substrate molecule.
|
1 | Q75JK0 (/IMP) |
Cellular response to drug GO:0035690
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a drug stimulus. A drug is a substance used in the diagnosis, treatment or prevention of a disease.
|
1 | P28028 (/IDA) |
Insulin secretion involved in cellular response to glucose stimulus GO:0035773
The regulated release of proinsulin from secretory granules (B granules) in the B cells of the pancreas; accompanied by cleavage of proinsulin to form mature insulin, in response to a glucose stimulus.
|
1 | Q99N57 (/IMP) |
Response to muscle stretch GO:0035994
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a myofibril being extended beyond its slack length.
|
1 | Q99N57 (/IMP) |
Regulation of cell population proliferation GO:0042127
Any process that modulates the frequency, rate or extent of cell proliferation.
|
1 | P28028 (/IGI) |
Regulation of cell fate specification GO:0042659
Any process that mediates the adoption of a specific fate by a cell.
|
1 | Q75JK0 (/IMP) |
CD4-positive, alpha-beta T cell differentiation GO:0043367
The process in which a relatively unspecialized T cell acquires specialized features of a mature CD4-positive, alpha-beta T cell.
|
1 | P28028 (/IMP) |
Positive T cell selection GO:0043368
The process of sparing immature T cells which react with self-MHC protein complexes with low affinity levels from apoptotic death.
|
1 | P28028 (/IMP) |
CD4-positive or CD8-positive, alpha-beta T cell lineage commitment GO:0043369
The process in which an immature T cell commits to CD4-positive T cell lineage or the CD8-positive lineage of alpha-beta T cells.
|
1 | P28028 (/IMP) |
Response to peptide hormone GO:0043434
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a peptide hormone stimulus. A peptide hormone is any of a class of peptides that are secreted into the blood stream and have endocrine functions in living animals.
|
1 | F1M9C3 (/IMP) |
Response to peptide hormone GO:0043434
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a peptide hormone stimulus. A peptide hormone is any of a class of peptides that are secreted into the blood stream and have endocrine functions in living animals.
|
1 | P28028 (/ISO) |
Negative regulation of neuron apoptotic process GO:0043524
Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process in neurons.
|
1 | P28028 (/ISO) |
Intermediate filament cytoskeleton organization GO:0045104
A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of cytoskeletal structures comprising intermediate filaments and their associated proteins.
|
1 | Q99N57 (/IMP) |
Regulation of T cell differentiation GO:0045580
Any process that modulates the frequency, rate or extent of T cell differentiation.
|
1 | P28028 (/IMP) |
Positive regulation of transcription by RNA polymerase II GO:0045944
Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter.
|
1 | Q99N57 (/IMP) |
Alpha-beta T cell differentiation GO:0046632
The process in which a precursor cell type acquires the specialized features of an alpha-beta T cell. An alpha-beta T cell is a T cell that expresses an alpha-beta T cell receptor complex.
|
1 | P28028 (/IMP) |
Neurotrophin TRK receptor signaling pathway GO:0048011
A series of molecular signals initiated by the binding of a neurotrophin to a receptor on the surface of the target cell where the receptor possesses tyrosine kinase activity, and ending with regulation of a downstream cellular process, e.g. transcription.
|
1 | Q99N57 (/IMP) |
Regulation of axon regeneration GO:0048679
Any process that modulates the frequency, rate or extent of axon regeneration.
|
1 | P28028 (/IGI) |
Positive regulation of axon regeneration GO:0048680
Any process that activates, maintains or increases the rate of axon regeneration.
|
1 | P28028 (/IDA) |
Positive regulation of axonogenesis GO:0050772
Any process that activates or increases the frequency, rate or extent of axonogenesis.
|
1 | P28028 (/IGI) |
Positive regulation of axonogenesis GO:0050772
Any process that activates or increases the frequency, rate or extent of axonogenesis.
|
1 | P28028 (/IMP) |
T cell receptor signaling pathway GO:0050852
A series of molecular signals initiated by the cross-linking of an antigen receptor on a T cell.
|
1 | P28028 (/IDA) |
Protein heterooligomerization GO:0051291
The process of creating protein oligomers, compounds composed of a small number, usually between three and ten, of component monomers that are not all identical. Oligomers may be formed by the polymerization of a number of monomers or the depolymerization of a large protein polymer.
|
1 | F1M9C3 (/IPI) |
Protein heterooligomerization GO:0051291
The process of creating protein oligomers, compounds composed of a small number, usually between three and ten, of component monomers that are not all identical. Oligomers may be formed by the polymerization of a number of monomers or the depolymerization of a large protein polymer.
|
1 | P28028 (/ISO) |
Positive regulation of stress fiber assembly GO:0051496
Any process that activates or increases the frequency, rate or extent of the assembly of a stress fiber, a bundle of microfilaments and other proteins found in fibroblasts.
|
1 | P28028 (/IGI) |
Positive regulation of stress fiber assembly GO:0051496
Any process that activates or increases the frequency, rate or extent of the assembly of a stress fiber, a bundle of microfilaments and other proteins found in fibroblasts.
|
1 | P28028 (/IMP) |
Response to cAMP GO:0051591
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cAMP (cyclic AMP, adenosine 3',5'-cyclophosphate) stimulus.
|
1 | F1M9C3 (/IMP) |
Response to cAMP GO:0051591
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cAMP (cyclic AMP, adenosine 3',5'-cyclophosphate) stimulus.
|
1 | P28028 (/ISO) |
Regulation of aggregation involved in sorocarp development GO:0060176
Any process that modulates the frequency, rate or extent of aggregation during sorocarp development. Aggregation involved in sorocarp development is the process whose specific outcome is the progression of the aggregate over time, from its formation to the point when a slug is formed. Aggregate development begins in response to starvation and continues by the chemoattractant-mediated movement of cells toward each other. The aggregate is a multicellular structure that gives rise to the slug.
|
1 | Q75JK0 (/IMP) |
Long-term synaptic potentiation GO:0060291
A process that modulates synaptic plasticity such that synapses are changed resulting in the increase in the rate, or frequency of synaptic transmission at the synapse.
|
1 | P28028 (/IMP) |
Head morphogenesis GO:0060323
The process in which the anatomical structures of the head are generated and organized. The head is the anterior-most division of the body.
|
1 | P28028 (/IMP) |
Regulation of positive chemotaxis to cAMP GO:0061118
Any process that modulates the rate, frequency, or extent of directed movement of a motile cell or organism up a concentration gradient of 3',5'-cAMP.
|
1 | Q75JK0 (/IMP) |
Positive regulation of ERK1 and ERK2 cascade GO:0070374
Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the ERK1 and ERK2 cascade.
|
1 | P28028 (/ISO) |
Trehalose metabolism in response to stress GO:0070413
The chemical reactions and pathways involving trehalose that occur as a result of a stimulus indicating the organism is under stress.
|
1 | P28028 (/ISO) |
Cellular response to calcium ion GO:0071277
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a calcium ion stimulus.
|
1 | P28028 (/ISO) |
Death-inducing signaling complex assembly GO:0071550
A process of protein complex assembly in which the arrangement and bonding together of the set of components that form the protein complex is mediated by a death domain (DD) interaction, as part of the extrinsic apoptotic signaling pathway.
|
1 | Q99N57 (/IMP) |
Establishment of protein localization to membrane GO:0090150
The directed movement of a protein to a specific location in a membrane.
|
1 | P28028 (/ISO) |
Positive regulation of substrate adhesion-dependent cell spreading GO:1900026
Any process that activates or increases the frequency, rate or extent of substrate adhesion-dependent cell spreading.
|
1 | P28028 (/IMP) |
Negative regulation of extrinsic apoptotic signaling pathway via death domain receptors GO:1902042
Any process that stops, prevents or reduces the frequency, rate or extent of extrinsic apoptotic signaling pathway via death domain receptors.
|
1 | Q99N57 (/IGI) |
Negative regulation of extrinsic apoptotic signaling pathway via death domain receptors GO:1902042
Any process that stops, prevents or reduces the frequency, rate or extent of extrinsic apoptotic signaling pathway via death domain receptors.
|
1 | Q99N57 (/IMP) |
Cellular response to nerve growth factor stimulus GO:1990090
A process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a nerve growth factor stimulus.
|
1 | F1M9C3 (/IEP) |
Negative regulation of synaptic vesicle exocytosis GO:2000301
Any process that stops, prevents or reduces the frequency, rate or extent of synaptic vesicle exocytosis.
|
1 | P28028 (/IMP) |
Negative regulation of endothelial cell apoptotic process GO:2000352
Any process that stops, prevents or reduces the frequency, rate or extent of endothelial cell apoptotic process.
|
1 | P28028 (/IMP) |
There are 26 GO terms relating to "cellular component"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
Cytoplasm GO:0005737
All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
|
26 |
A7E3S4 (/ISS)
P04049 (/ISS)
P04049 (/ISS)
P04049 (/ISS)
P04049 (/ISS)
P04049 (/ISS)
P04049 (/ISS)
P04049 (/ISS)
P04049 (/ISS)
P04049 (/ISS)
(16 more) |
Cytosol GO:0005829
The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
|
23 |
P04049 (/TAS)
P04049 (/TAS)
P04049 (/TAS)
P04049 (/TAS)
P04049 (/TAS)
P04049 (/TAS)
P04049 (/TAS)
P04049 (/TAS)
P04049 (/TAS)
P10398 (/TAS)
(13 more) |
Nuclear speck GO:0016607
A discrete extra-nucleolar subnuclear domain, 20-50 in number, in which splicing factors are seen to be localized by immunofluorescence microscopy.
|
20 |
A0A0S2Z559 (/IDA)
A0A0S2Z559 (/IDA)
L7RRS6 (/IDA)
L7RRS6 (/IDA)
L7RRS6 (/IDA)
L7RRS6 (/IDA)
L7RRS6 (/IDA)
L7RRS6 (/IDA)
L7RRS6 (/IDA)
L7RRS6 (/IDA)
(10 more) |
Plasma membrane GO:0005886
The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
|
17 |
A7E3S4 (/ISS)
P05625 (/ISS)
P05625 (/ISS)
P09560 (/ISS)
P11346 (/ISS)
P11346 (/ISS)
P11346 (/ISS)
Q5R5M7 (/ISS)
Q5R5M7 (/ISS)
Q5R5M7 (/ISS)
(7 more) |
Plasma membrane GO:0005886
The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
|
16 |
P04049 (/TAS)
P04049 (/TAS)
P04049 (/TAS)
P04049 (/TAS)
P04049 (/TAS)
P04049 (/TAS)
P04049 (/TAS)
P04049 (/TAS)
P04049 (/TAS)
P11346 (/TAS)
(6 more) |
Cytosol GO:0005829
The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
|
13 |
P04049 (/IDA)
P04049 (/IDA)
P04049 (/IDA)
P04049 (/IDA)
P04049 (/IDA)
P04049 (/IDA)
P04049 (/IDA)
P04049 (/IDA)
P04049 (/IDA)
P14056 (/IDA)
(3 more) |
Plasma membrane GO:0005886
The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
|
12 |
F1M9C3 (/IDA)
P04049 (/IDA)
P04049 (/IDA)
P04049 (/IDA)
P04049 (/IDA)
P04049 (/IDA)
P04049 (/IDA)
P04049 (/IDA)
P04049 (/IDA)
P04049 (/IDA)
(2 more) |
Cytoplasm GO:0005737
All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
|
11 |
P04049 (/IDA)
P04049 (/IDA)
P04049 (/IDA)
P04049 (/IDA)
P04049 (/IDA)
P04049 (/IDA)
P04049 (/IDA)
P04049 (/IDA)
P04049 (/IDA)
P11345 (/IDA)
(1 more) |
Mitochondrial outer membrane GO:0005741
The outer, i.e. cytoplasm-facing, lipid bilayer of the mitochondrial envelope.
|
9 | P04049 (/TAS) P04049 (/TAS) P04049 (/TAS) P04049 (/TAS) P04049 (/TAS) P04049 (/TAS) P04049 (/TAS) P04049 (/TAS) P04049 (/TAS) |
Golgi apparatus GO:0005794
A compound membranous cytoplasmic organelle of eukaryotic cells, consisting of flattened, ribosome-free vesicles arranged in a more or less regular stack. The Golgi apparatus differs from the endoplasmic reticulum in often having slightly thicker membranes, appearing in sections as a characteristic shallow semicircle so that the convex side (cis or entry face) abuts the endoplasmic reticulum, secretory vesicles emerging from the concave side (trans or exit face). In vertebrate cells there is usually one such organelle, while in invertebrates and plants, where they are known usually as dictyosomes, there may be several scattered in the cytoplasm. The Golgi apparatus processes proteins produced on the ribosomes of the rough endoplasmic reticulum; such processing includes modification of the core oligosaccharides of glycoproteins, and the sorting and packaging of proteins for transport to a variety of cellular locations. Three different regions of the Golgi are now recognized both in terms of structure and function: cis, in the vicinity of the cis face, trans, in the vicinity of the trans face, and medial, lying between the cis and trans regions.
|
9 | P04049 (/IPI) P04049 (/IPI) P04049 (/IPI) P04049 (/IPI) P04049 (/IPI) P04049 (/IPI) P04049 (/IPI) P04049 (/IPI) P04049 (/IPI) |
Cytosol GO:0005829
The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
|
3 | P04627 (/ISO) P28028 (/ISO) Q99N57 (/ISO) |
Intracellular membrane-bounded organelle GO:0043231
Organized structure of distinctive morphology and function, bounded by a single or double lipid bilayer membrane and occurring within the cell. Includes the nucleus, mitochondria, plastids, vacuoles, and vesicles. Excludes the plasma membrane.
|
3 | P15056 (/IDA) P15056 (/IDA) P15056 (/IDA) |
Mitochondrion GO:0005739
A semiautonomous, self replicating organelle that occurs in varying numbers, shapes, and sizes in the cytoplasm of virtually all eukaryotic cells. It is notably the site of tissue respiration.
|
2 | P04627 (/IDA) P28028 (/IDA) |
Plasma membrane GO:0005886
The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
|
2 | P28028 (/ISO) Q99N57 (/ISO) |
Neuron projection GO:0043005
A prolongation or process extending from a nerve cell, e.g. an axon or dendrite.
|
2 | F1M9C3 (/IDA) P28028 (/IDA) |
Nucleus GO:0005634
A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
|
1 | F1M9C3 (/IDA) |
Nucleus GO:0005634
A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
|
1 | P28028 (/ISO) |
Cytoplasm GO:0005737
All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
|
1 | Q99N57 (/ISO) |
Golgi apparatus GO:0005794
A compound membranous cytoplasmic organelle of eukaryotic cells, consisting of flattened, ribosome-free vesicles arranged in a more or less regular stack. The Golgi apparatus differs from the endoplasmic reticulum in often having slightly thicker membranes, appearing in sections as a characteristic shallow semicircle so that the convex side (cis or entry face) abuts the endoplasmic reticulum, secretory vesicles emerging from the concave side (trans or exit face). In vertebrate cells there is usually one such organelle, while in invertebrates and plants, where they are known usually as dictyosomes, there may be several scattered in the cytoplasm. The Golgi apparatus processes proteins produced on the ribosomes of the rough endoplasmic reticulum; such processing includes modification of the core oligosaccharides of glycoproteins, and the sorting and packaging of proteins for transport to a variety of cellular locations. Three different regions of the Golgi are now recognized both in terms of structure and function: cis, in the vicinity of the cis face, trans, in the vicinity of the trans face, and medial, lying between the cis and trans regions.
|
1 | Q99N57 (/ISO) |
Membrane GO:0016020
A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it.
|
1 | F1M9C3 (/IDA) |
Membrane GO:0016020
A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it.
|
1 | P28028 (/ISO) |
Nuclear speck GO:0016607
A discrete extra-nucleolar subnuclear domain, 20-50 in number, in which splicing factors are seen to be localized by immunofluorescence microscopy.
|
1 | Q99N57 (/ISO) |
Pseudopodium GO:0031143
A temporary protrusion or retractile process of a cell, associated with flowing movements of the protoplasm, and serving for locomotion and feeding.
|
1 | Q99N57 (/IDA) |
Neuron projection GO:0043005
A prolongation or process extending from a nerve cell, e.g. an axon or dendrite.
|
1 | P28028 (/ISO) |
Intracellular membrane-bounded organelle GO:0043231
Organized structure of distinctive morphology and function, bounded by a single or double lipid bilayer membrane and occurring within the cell. Includes the nucleus, mitochondria, plastids, vacuoles, and vesicles. Excludes the plasma membrane.
|
1 | P28028 (/ISO) |
Cell body GO:0044297
The portion of a cell bearing surface projections such as axons, dendrites, cilia, or flagella that includes the nucleus, but excludes all cell projections.
|
1 | P28028 (/IDA) |